Treatment of tuberous sclerosis complex manifestations in children with mTOR inhibitors.
Süleyman YeşilBurçak KurucuMelda Berber HamamcıŞükriye YılmazGürses ŞahinPublished in: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery (2023)
The utilization of mTOR inhibition in TSC is expected to become more prevalent in clinical practice, as current research is anticipated to provide a better understanding of the therapeutic roles of these treatments in TSC.